Hedge Fund - ARK Investment Management
Crispr Therapeutics Ag (CRSP)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $345,928,566 | 3.46% | 10,165,400 | $42.39 |
| 2 | 2024 - Q4 (2024-12-31) | $353,179,787 | 2.94% | 8,973,064 | $47.22 |
| 3 | 2024 - Q3 (2024-09-30) | $352,285,403 | 3.22% | 7,498,625 | $50.74 |
| 4 | 2024 - Q2 (2024-06-30) | $420,118,712 | 3.72% | 7,778,536 | $57.84 |
| 5 | 2024 - Q1 (2024-03-31) | $555,983,010 | 3.84% | 8,157,028 | $71.59 |
| 6 | 2023 - Q4 (2023-12-31) | $534,360,111 | 3.16% | 8,536,104 | $55.02 |
| 7 | 2023 - Q3 (2023-09-30) | $325,133,913 | 2.48% | 7,163,118 | $51.65 |
| 8 | 2023 - Q2 (2023-06-30) | $411,980,394 | 2.72% | 7,338,447 | $56.74 |
| 9 | 2023 - Q1 (2023-03-31) | $361,396,203 | 2.48% | 7,990,188 | $48.57 |
| 10 | 2022 - Q4 (2022-12-31) | $318,286,736 | 2.75% | 7,829,932 | $53.05 |
| 11 | 2022 - Q3 (2022-09-30) | $538,296,000 | 3.75% | 8,237,122 | $72.47 |
| 12 | 2022 - Q2 (2022-06-30) | $564,683,000 | 3.33% | 9,727,531 | $58.79 |
| 13 | 2022 - Q1 (2022-03-31) | $590,294,000 | 2.46% | 9,404,071 | $62.79 |
| 14 | 2021 - Q4 (2021-12-31) | $688,679,000 | 2.08% | 9,087,868 | $87.36 |
| 15 | 2021 - Q3 (2021-09-30) | $849,064,000 | 2.03% | 7,585,674 | $125.59 |
| 16 | 2021 - Q2 (2021-06-30) | $1,258,876,000 | 2.34% | 7,776,119 | $121.62 |
| 17 | 2021 - Q1 (2021-03-31) | $1,010,179,000 | 2% | 8,290,350 | $151.00 |
| 18 | 2020 - Q4 (2020-12-31) | $1,594,331,000 | 4.24% | 10,412,976 | $118.20 |
| 19 | 2020 - Q3 (2020-09-30) | $707,370,000 | 4.19% | 8,457,320 | $88.70 |
| 20 | 2020 - Q2 (2020-06-30) | $476,454,000 | 5.12% | 6,483,251 | $58.47 |
| 21 | 2020 - Q1 (2020-03-31) | $181,754,000 | 4.52% | 4,285,632 | $51.63 |
| 22 | 2019 - Q4 (2019-12-31) | $180,074,000 | 4.54% | 2,956,635 | $54.60 |
| 23 | 2019 - Q3 (2019-09-30) | $114,040,000 | 2.48% | 2,782,140 | $47.78 |
| 24 | 2019 - Q2 (2019-06-30) | $128,317,000 | 3.23% | 2,724,349 | $39.97 |
| 25 | 2019 - Q1 (2019-03-31) | $72,262,000 | 2.06% | 2,023,017 | $34.57 |
| 26 | 2018 - Q4 (2018-12-31) | $37,858,000 | 1.53% | 1,325,110 | $34.76 |
| 27 | 2018 - Q3 (2018-09-30) | $64,467,000 | 1.94% | 1,453,590 | $52.37 |
| 28 | 2018 - Q2 (2018-06-30) | $27,449,000 | 1% | 467,140 | $56.97 |
| 29 | 2018 - Q1 (2018-03-31) | $3,316,000 | 0.16% | 72,534 | $41.27 |
| 30 | 2017 - Q2 (2017-06-30) | $206,000 | 0.04% | 12,888 | $16.52 |
The displayed share prices are average quarterly stock market prices.